World's Best Scientists 2026 revealed!
Award Badge
Rising Stars
2025
Award Badge
Molecular Biology
Iran
2026

D-Index & Metrics

Rising Stars

D-Index
60
Citations
13776
World Ranking
161
National Ranking
7

Molecular Biology

D-Index
64
Citations
14040
World Ranking
1749
National Ranking
2

Amir Avan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Amir Avan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 394 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Amir Avan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Amir Avan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 64 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Iran Leader Award
  • 2025 - Research.com Rising Stars Award

Overview

Amir Avan is affiliated with Mashhad University of Medical Sciences in Iran and has a significant presence in the fields of medicine and biochemistry, genetics, and molecular biology. Their research output includes 216 publications in medicine and 154 in biochemistry, genetics, and molecular biology, with notable contributions across various subfields such as molecular biology, oncology, cancer research, surgery, and genetics.

Their research covers a diverse spectrum of cancer-related topics and molecular mechanisms, reflecting an emphasis on pancreatic and hepatic oncology, colorectal cancer, nanoplatforms for cancer theranostics, and the role of microRNA in disease regulation.

  • Pancreatic and Hepatic Oncology Research
  • Cancer-related molecular mechanisms research
  • Colorectal Cancer Treatments and Studies
  • Nanoplatforms for cancer theranostics
  • MicroRNA in disease regulation
  • Cancer Research and Treatments
  • Intestinal and Peritoneal Adhesions

Amir Avan has frequently published in venues such as:

  • Current Pharmaceutical Design
  • PubMed
  • Life Sciences
  • Letters in Drug Design & Discovery
  • Current Cancer Drug Targets

Among their recent papers are:

  • Early-stage cervical cancer diagnosis based on an ultra-sensitive electrochemical DNA nanobiosensor for HPV-18 detection in real samples, 2020, Journal of Nanobiotechnology
  • Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC), 2021, Cancers
  • Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer, 2020, Gene
  • Bacteria and cancer: Different sides of the same coin, 2020, Life Sciences
  • The bacterial instrument as a promising therapy for colon cancer, 2020, International Journal of Colorectal Disease

Collaborations play a notable role in their work, with frequent co-authors including:

  • Majid Khazaei
  • Gordon A. Ferns
  • Seyed Mahdi Hassanian
  • Fereshteh Asgharzadeh
  • Seyedeh Elnaz Nazari

The range of research topics, publication venues, and co-author network indicates an interdisciplinary approach predominantly focused on cancer biology, therapeutic strategies, and molecular diagnostics within oncology and related biomedical sciences.

Best Publications

  • The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials

    Maryam Moradi Binabaj;Afsane Bahrami;Soodabeh ShahidSales;Marjan Joodi

  • Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

    Abolfazl Avan;Tjeerd J. Postma;Cecilia Ceresa;Amir Avan

  • Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.

    R Nedaeinia;M Manian;M H Jazayeri;M Ranjbar

  • Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells.

    Faezeh Ghasemi;Mojtaba Shafiee;Zarrin Banikazemi;Mohammad Hossein Pourhanifeh

  • Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.

    Afsane Bahrami;Forouzan Amerizadeh;Soodabeh ShahidSales;Majid Khazaei

  • Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer

    Reyhaneh Moradi Marjaneh;Farzad Rahmani;Seyed Mahdi Hassanian;Nastaran Rezaei

  • MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.

    Hamed Mirzaei;Sharareh Gholamin;Soodabeh Shahidsales;Amirhossein Sahebkar

  • Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia

    M Maftouh;A Avan;R Sciarrillo;Carlotta Granchi

  • Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice

    Amir Avan;Seyedeh Belin Tavakoly Sany;Majid Ghayour-Mobarhan;Hamid Reza Rahimi

  • Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer.

    Safieh Ebrahimi;Mina Hosseini;Soodabeh Shahidsales;Mina Maftouh

  • The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs

    Afsane Bahrami;Amir Aledavood;Kazem Anvari;Seyed Mahdi Hassanian

  • Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer.

    Atena Soleimani;Farzad Rahmani;Gordon A. Ferns;Mikhail Ryzhikov

  • Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress: Wnt PATHWAY INCRC

    Afsane Bahrami;Forouzan Amerizadeh;Soodabeh ShahidSales;Majid Khazaei

  • Early detection of colorectal cancer: from conventional methods to novel biomarkers

    Nasimeh Vatandoost;Jahanafrooz Ghanbari;Mahboobeh Mojaver;Amir Avan

  • Hereditary breast cancer; Genetic penetrance and current status with BRCA.

    Morteza Mahdavi;Mohammadreza Nassiri;Mohammad Mahdi Kooshyar;Masoume Vakili-Azghandi

  • The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy

    Afsane Bahrami;Malihe Hasanzadeh;Seyed Mahdi Hassanian;Soodabeh ShahidSales

  • Podophyllotoxin: a novel potential natural anticancer agent.

    Hamidreza Ardalani;Amir Avan;Majid Ghayour-Mobarhan

  • Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives

    Hamed Mirzaei;Sara Khataminfar;Saeid Mohammadparast;Soudabeh Shahid Sales

  • Genetic and epigenetic factors influencing vitamin D status.

    Afsane Bahrami;Hamid Reza Sadeghnia;Seyed‐Amir Tabatabaeizadeh;Hamidreza Bahrami‐Taghanaki

  • Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells

    Amir Avan;Francesco Crea;Elisa Paolicchi;Niccola Funel

Frequent Co-Authors

Gordon A. Ferns
Gordon A. Ferns Brighton and Sussex Medical School
Godefridus J. Peters
Godefridus J. Peters Gdańsk Medical University
Hamed Mirzaei
Hamed Mirzaei Kashan University of Medical Sciences
Amirhossein Sahebkar
Amirhossein Sahebkar Mashhad University of Medical Sciences
William C S Cho
William C S Cho Hospital Authority
Henk M.W. Verheul
Henk M.W. Verheul Radboud University
Majid Darroudi
Majid Darroudi Mashhad University of Medical Sciences
Michele Milella
Michele Milella University of Verona
Mahmoud Reza Jaafari
Mahmoud Reza Jaafari Mashhad University of Medical Sciences
Michele Reni
Michele Reni Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology in the USA opens up a range of related online degree and career options. Students interested in communication sciences may consider joining asha accredited online slp programs, which offer flexible learning while ensuring professional standards. For those with a non-SLP background, slp bridge programs provide the necessary foundation to transition into speech-language pathology roles.

If you are considering a career switch into healthcare, pursuing a nursing degree is also a viable option. Many universities now offer non nursing degree to bsn online programs, which allow you to fast-track your way to becoming a registered nurse—even if your undergraduate studies were in another field.

Additionally, careers like psychiatric nurse practitioner are in high demand. When evaluating your earning potential, it's helpful to review information on psychiatric nurse practitioner salary by state. These pathways demonstrate that molecular biology graduates have many options for further education and specialized healthcare roles.

Best Scientists Citing Amir Avan

Trending Scientists

Recently Published Articles